根據(jù)一項最新研究發(fā)現(xiàn)，與其他嬰兒相比，新生兒黃疸的診斷與治療不會影響嬰兒的遠期發(fā)育。

美國San Francisco的California大學(UCSF, USA)與Kaiser Permanente的研究分部(Oakland, CA, USA)的研究人員，比較了140膽紅素水平在25 mg/dl和30 mg/dl之間的嬰兒（該水平在700例新生兒中只有1例能夠達到）和400多例的對照嬰兒。研究人員對這些兒童進行了隨訪直到5歲，檢測他們的智商(IQ)、神經(jīng)系統(tǒng)，并對其父母進行訪問。他們結(jié)果發(fā)現(xiàn)在IQ或者行為方面、或者發(fā)生異常神經(jīng)系統(tǒng)檢查結(jié)果或者疾病診斷的兒童比例等方面，黃疸兒童與對照兒童之間沒有顯著性差異。這些研究結(jié)果發(fā)表在2006年5月《新英格蘭醫(yī)學期刊之上》。
 
Newborns With Jaundice Develop Normally
 
Newborn babies who are diagnosed with and treated for jaundice are no more likely than other babies to suffer long-term developmental problems, according to a new study.

Researchers from the University of California, San Francisco (UCSF, USA) and Kaiser Permanente's Division of Research (Oakland, CA, USA) compared 140 infants with bilirubin levels of between 25 mg/dl and 30 mg/dl--a level reached by only about 1 in 700 newborns---to more than 400 control infants. The researchers followed the children up to five years of age, measuring intelligence quotient (IQ), performing neurologic exams, and interviewing parents. They found no significant difference between jaundiced and control newborns in IQ or behavior, or in the proportion of children with abnormal neurologic examinations or with neurologic diagnoses. The study was published in the May 4, 2006, issue of the New England Journal of Medicine.